重组人RANK L(TRANCE)(TNFSF11)

特别提示：包括重组人RANK L(TRANCE)(TNFSF11)在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！

产品名称：重组人RANK L(TRANCE)(TNFSF11)
英文名称：Recombinant Human Receptor Activator of NF-kappa-B ligand
产品货号：JN0491
产品规格：10μg|50μg|500μg|1mg

本品由我们的大肠杆菌表达系统制备而成，目的基因编码的Ile140-Asp317在N端含有His标签。

RANK L/TRANCE/TNFSF11质量控制：＞95%(还原性SDS-PAGE)


RANK L/TRANCE/TNFSF11制剂：冻干品

RANK L/TRANCE/TNFSF11保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

RANK L/TRANCE/TNFSF11复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于RANK L/TRANCE/TNFSF11：
CD254, also known as RANKL, TNFSF11, TRANCE, OPGL and ODF, is a type II membrane protein of the tumor necrosis factor (TNF) superfamily, and affects the immune system and control bone regeneration and remodeling. RANKL is the ligand of nuclear factor (NF)-κB (RANK). When RANKL binds to RANK, it will undergo trimerization and then bind to an adaptor molecule TNF receptor-associated factor 6 (TRAF6). This results in the activation of several downstream signaling cascades, including the NFκB, mitogen-activated protein kinases (MAPK), activating protein 1 (AP-1), and nuclear factor of activated T cells (NFATc1), resulting in the formation of multinucleated bone-resorbing osteoclasts. RANKL is widely expressed in skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoblast, mammary gland epithelial cells, prostate and pancreas.

我公司销售的重组人RANK L(TRANCE)(TNFSF11)，重组人TRANCE，rTRANCE，Recombinant Human Receptor Activator of NF-kappa-B ligand，重组TRANCE，rhTNFSF11，重组人TNFSF11，重组人RANK L，重组RANK L，rTNFSF11，重组Receptor Activator of NF-kappa-B ligand，重组人Receptor Activator of NF-kappa-B ligand，rhTRANCE，重组TNFSF11质量上佳，价格普惠，欢迎广大新老客户踊跃订购。